In this episode, Dr. C. Joe Northup, MD, FACS, FASMBS, Bariatric Surgeon & 40th President of the American Society for Metabolic and Bariatric Surgery (ASMBS), discusses the impact of GLP-1 medications on bariatric surgery, the durability and safety of surgical treatment, and expanding access to obesity care. He also shares leadership lessons, the future of metabolic care, and why obesity should be treated as a disease rather than a character flaw.
The Future of Bariatric Surgery in the GLP-1 Era with Dr. C. Joe Northup
Next Up in Becker's Healthcare Podcast Episodes
-
In this episode, Dr. Ali Khan, Chief Medical Officer, Aetna Medicare, discusses new findings showing how value-based care improves clinical…
-
In this episode, Mark J. Ricciardi, MD, Section Chief Interventional Cardiology and Structural Heart; Charles Walgreen Jr Chair, Endeavor Health…
-
In this episode, James C. Wittig, MD, Founder and CEO of Mandala Medical Group, discusses his holistic approach to cancer…
Comments are closed.